assessing the value of various prognostic biomarkers in al amyloidosis
Published 2 months ago • 34 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
2:20
new prognostic markers in al amyloidosis
-
1:25
prognostic and predictive biomarkers in cll and their potential in guiding treatment decisions
-
1:45
role for mrd assessment in al amyloidosis?
-
2:34
the impact of ethnicity on biomarker-based staging in al amyloidosis
-
2:00
time to next treatment as a prognostic marker in patients with al amyloidosis
-
2:38
unmet needs in imaging for the diagnosis of al amyloidosis
-
3:08
real-world data on treatment strategies and outcomes in systemic al amyloidosis
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
7:30
challenges in distinguishing al amyloidosis from attr amyloidosis
-
3:50
darcy tannehill: al amyloidosis diagnosis
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:08
challenges in understanding and diagnosing attr amyloidosis
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:52
monitoring, diagnosing & managing cardiotoxicity in al amyloidosis
-
1:03
real-world management of patients with al amyloidosis
-
1:21
the prognostic impact of secondary-type mutations in patients with favorable risk aml
-
1:45
real-world data in guiding amyloidosis treatment
-
1:38
an overview of the practical challenges in approaching r/r amyloidosis
-
2:56
early vs. deferred transplantation in al amyloidosis
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
1:33
prognostic impact of wt1 mutations in newly diagnosed and r/r aml